All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F16%3A10326077" target="_blank" >RIV/00064165:_____/16:10326077 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11110/16:10326077

  • Result on the web

    <a href="http://dx.doi.org/10.1080/14737175.2016.1181543" target="_blank" >http://dx.doi.org/10.1080/14737175.2016.1181543</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1080/14737175.2016.1181543" target="_blank" >10.1080/14737175.2016.1181543</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

  • Original language description

    Introduction: Brain atrophy measurement in multiple sclerosis (MS) has become an important outcome for determining patients at risk for developing physical and cognitive disability. Areas covered: In this article, we discuss the methodological issues related to using this MRI metric routinely, in a clinical setting. Understanding trajectories of annualized whole brain, gray and white matter, thalamic volume loss, and enlargement of ventricular space in specific MS phenotypes is becoming increasingly important. Evidence is mounting that disease-modifying treatments exert a positive effect on slowing brain atrophy progression in MS. Expert Commentary: While there is a need to translate measurement of brain atrophy to clinical routine at the individual patient level, there are still a number of challenges to be met before this can actually happen, including how to account for biological confounding factors and pseudoatrophy, standardize acquisition and analyses parameters, which can influence the accuracy of the assessments.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Expert Review of Neurotherapeutics

  • ISSN

    1473-7175

  • e-ISSN

  • Volume of the periodical

    16

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    17

  • Pages from-to

    777-793

  • UT code for WoS article

    000379025500007

  • EID of the result in the Scopus database

    2-s2.0-84976423714